Sector Gamma As Rigel Pharmaceuticals Inc Transaction History

Sector Gamma As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$1.1 - $12.2 $131,751 - $1.46 Million	-119,774 Reduced 8.17%	1,346,904 $1.59 Million
Q1 2022 May 06, 2022	SELL	$2.22 - $3.45 $6,495 - $10,094	-2,926 Reduced 0.2%	1,466,678 $4.39 Million
Q4 2021 Feb 08, 2022	SELL	$2.36 - $3.57 $715,377 - $1.08 Million	-303,126 Reduced 17.1%	1,469,604 $3.89 Million
Q3 2021 Oct 29, 2021	BUY	$3.5 - $4.5 $235,119 - $302,296	67,177 Added 3.94%	1,772,730 $6.44 Million
Q2 2021 Aug 04, 2021	BUY	$3.09 - $4.54 $540,944 - $794,786	175,063 Added 11.44%	1,705,553 $7.4 Million
Q1 2021 May 10, 2021	SELL	$3.35 - $4.93 $228,332 - $336,023	-68,159 Reduced 4.26%	1,530,490 $5.23 Million
Q4 2020 Feb 10, 2021	BUY	$2.35 - $3.74 $548,403 - $872,777	233,363 Added 17.09%	1,598,649 $5.6 Million
Q3 2020 Nov 09, 2020	BUY	$1.78 - $4.13 $2.43 Million - $5.64 Million	1,365,286 New	1,365,286 $3.28 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.84B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.